Objective: To investigate the effect of rapeseed oil-based cheese (milk-fat substituted by rapeseed oil) on serum total and lipoprotein lipid concentrations and blood pressure in reference to ordinary, milk-fat-based cheese in subjects with mildly to moderately elevated serum cholesterol concentration. Design: Randomized, controlled, single-blind, cross-over clinical trial. Settings: Outpatient dietary intervention with free-living subjects in Eastern Finland. Interventions: The study began with a 2 week pre-trial period followed by two 4 week intervention periods. During the intervention study subjects replaced their ordinary cheese or cold cuts with 65 g of rapeseed oil-based or milk-fat-based control cheese. The type of test cheese was switched at 4 weeks of intervention. Altogether 31 subjects completed the study. Results: Compared with the control cheese period the mean serum total cholesterol concentration was 6.7% (95% Cl 7 9.9 to 7 3.5%) lower after 2 weeks and 5.0% (95% Cl 7 7.5 to 7 2.5%) lower after 4 weeks of use of rapeseed oil-based cheese. Respectively, LDL cholesterol concentration was 7.0% (95% Cl 7 11.7 to 7 2.6%) lower after 2 weeks use and 6.4% (95% Cl 7 10.0 to 7 2.8%) lower after 4 weeks' use of rapeseed oil-based cheese. Conclusions: The present study showed that the rapeseed oil-based cheese reduces serum total and LDL cholesterol concentrations in mildly to moderately hypercholesterolemic subjects when replacing ordinary milk-fat-based cheese in the diet. Sponsorship:
Introduction
Cheese consumption has been steadily increasing over the past 20 y (Putnam & Allshouse 1999) . The average cheese consumption per capita in the USA is 12.7 kg=y (Putnam & Allshouse, 1999) and in the European Union countries 17 kg=y (King, 1999) . Cheese and other milk products are major sources of saturated fat, since over 60% of dairy fat is saturated.
A diet rich in saturated fat increases serum total and LDL cholesterol concentrations, while replacing saturated fat by unsaturated fat reduces cholesterol concentrations (Mensink & Katan, 1992; Hegsted et al, 1993) . Modern food technology allows substitution of highly saturated milk fat by rapeseed oil, low in saturated fat, in cheese manufacturing. This might give new opportunities to control elevated serum cholesterol concentration, which is known to be one of the most important risk factors for atherosclerotic vascular diseases (Assmann et al, 1999) . Replacing one slice (10 g) of ordinary medium-fat cheese with vegetable oil-based cheese reduces the intake of saturated fat by more than 1 g (Rastas et al, 1997 ; calculated using the Micro-Nutrica 1 dietary analysis software developed by The Social Insurance Institution, Finland). In addition, the intake of unsaturated fat increases simultaneously in the diet via the vegetable oil used in cheese manufacturing.
Recently, During et al (2000) demonstrated that feeding Wistar rats with fat-modified cheese instead of milk-fat-based cheese resulted in a significant decrease in LDL cholesterol and LDL=HDL cholesterol ratio. Sunflower and soybean oilenriched skim-milk cheese also increased fecal excretion of endogenous cholesterol, when compared with ordinary cheese. In a previous cross-over study by Davis et al (1993) , vegetable oil-based mozzarella cheese reduced serum total and LDL cholesterol concentrations in moderately hypercholesterolemic subjects, when compared with the cholesterol concentration at the baseline or after consumption of partially skim-milk-based mozzarella. The daily consumption of cheese in their study was high -the mean intake was reported to be 100 g.
In addition, there are some data that calcium may prevent absorption of cholesterol and increase cholesterol excretion to feces to some extent and thus reduce serum cholesterol concentrations. However, this effect is likely to be very minor (Ritz et al, 1980) .
There is preliminary evidence of the cholesterol-lowering effects of fat-modified cheeses, but there are no previous studies on cholesterol-lowering properties of rapeseed oilbased cheese at a moderate level of cheese intake. Furthermore, the effect of fat-modified cheeses should be documented in subjects with hypercholesterolemia, who constitute the principal target population of cholesterol-lowering food products.
The aim of the study was to investigate the effect of rapeseed oil-based cheese (milk-fat substituted by rapeseed oil) on serum total and lipoprotein lipids in reference to ordinary, milk-fat-based cheese in subjects with mildly to moderately elevated serum cholesterol concentrations.
Methods

Subjects
Inclusion criteria of the study were serum total cholesterol between 5.0 and 8.0 mmol=l, serum total triacylglycerol below 3.0 mmol=l, age 25 -65 y, normal liver, kidney and thyroid function, no lipid lowering medication, no history of unstable coronary artery disease (myocardial infarction, coronary artery bypass craft (CABG), percutaneous transluminal coronary angioplasty (PTCA) within the previous 6 months), diabetes, transient ischemic attack or malignant diseases. Subjects reporting alcohol use, of more than 50 g of ethanol=per day in the interview were excluded. Subjects with irregular eating habits, food allergies or other difficulties in consuming the test products were excluded. The inclusion criteria were checked during the run-in period before randomization. The purpose of the study was explained to the participants, and a written consent to the study was given by all of the subjects.
Subjects were recruited by an advertizement in a local newspaper and from the register of volunteers of Foodfiles Ltd in Kuopio area, Eastern Finland. Altogether 34 subjects with mild to moderate hypercholesterolemia were recruited to the study. One subject was excluded due to normocholestrolemic values at screening. One subject withdrew from the study at the end of the run-in period because she started a low-calorie diet. Finally, of the 32 subjects who were randomized, 31 completed the study (overall participation rate was 97%). One subject completing the study protocol was excluded from the final data due to a difficult, long-term influenza during the trial. Pre-trial characteristics of the final 31 study subjects are presented in Table 1 .
A structured interview on previous and present diseases was carried out in the beginning of the study to ensure the eligibility of the subjects. Routine laboratory measurements (blood count, serum thyroid-stimulating hormone, serum glutamyl transferase, serum creatinine, serum urate, plasma glucose) of all the study subjects were within normal ranges.
During the intervention two of the subjects received medical treatment for hypertension, seven used postmenopausal hormone replacement therapy or hormonal contraceptives and two received other medication (one for treatment of rheumatic disease and one for the treatment of prostatic problems). According to the structured interview 42% of the subjects used vitamin or mineral supplements, 19% used natural or herbal foods or organic remedies and 35% consumed serum lipid-affecting functional foods before the study. All lipid-lowering agents and therapies, including fish oil and other oil supplements and functional foods, were discontinued a month before the intervention. Postmenopausal hormonal replacement therapy was not discontinued. At the beginning of the study 90% of the subjects had regular exercise, 22% of the subjects smoked and 84% used alcohol. The subjects were requested to keep their medication, alcohol consumption, smoking habits, physical activity and use of vitamins and other nutrient supplements constant during the study. During the study the subjects recorded daily the changes in their health status, medication and lifestyle. A structured interview on alcohol and tobacco consumption, medication and physical activity was repeated at the end of the study.
Study design and diets
A randomized, single blind, placebo-controlled cross-over design was used. After a 2 week run-in period all subjects followed both of two 4 week test periods (Figure 1 ). Half of the group ate ordinary cheese first and the other half started with the fat-modified cheese. Effect of vegetable oil-based cheese HM Karvonen et al
During the test period study subjects ate low-fat rapeseed oilbased cheese and during the control period they ate normal, moderate-fat, milk-fat-based hard cheese. The vegetable oil based cheese contained 17% rapeseed oil, but no other fat.
The daily portion of test products was 65 g. The daily portion of test product provided 11 g fat of which under 1 g was saturated fat. The daily portion of control product equalled the amount of test cheese, which provided 15 g fat of which 10 g was saturated fat. All subjects consumed the same amount of cheese irrespective of their energy level. The difference in the intake of saturated fat from test cheeses was 9 g between the test periods. Full nutritional information of the study cheeses is given in Table 2 . The study subjects followed their habitual diet except for the use of test cheeses. The clinical nutritionist advised the study subjects to keep the fat intake from the background diet unchanged throughout the study. Subjects were instructed to replace the habitual cheese they used with the test cheese. In addition, subjects accustomed to use less than 65 g of cheese a day were also instructed to reduce the use of cold cuts or fatty bakery goods to keep the diets isocaloric during both test and control periods. All subjects received individual oral and written instructions on the diet. The test products were delivered free of charge for the participants. The use of test products was recorded daily and the nutritionist checked the records at each visit. In addition, the study participants returned the empty and partly eaten packages of test cheese into the study unit at the end of each test period.
The subjects were advised to keep their weight constant during the study. The composition of the background diet was monitored by 4 day food records. During each study period subjects recorded dietary intake in food records for four consecutive days, including one weekend day or the person's day off from work. Serving sizes were estimated with a portion size picture booklet (Pietinen et al, 1988) . Oral instructions on how to record foods were given to all subjects personally and written instructions were also given. At the study visits the food records were checked by the clinical nutritionist for completion, filling in the data that were lacking. Nutrients were calculated using the Micro-Nutrica 1 dietary analysis software (developed by The Social Insurance Institution, Finland), which is mainly based on the national nutrient composition data.
The study design was approved by the Ethics Committee of the Kuopio University Hospital and University of Kuopio.
Laboratory measurements
All of the blood samples were drawn after an overnight (12 h) fast. Blood samples for cholesterol analysis were drawn to BD Vacutainer serum tubes (Bector Dickinson CDD, UK). Serum Effect of vegetable oil-based cheese HM Karvonen et al samples were stored in refrigerator ( þ 4 C) until analysis for 3 -5 days. Serum total and HDL cholesterol and total triacylglycerol were analyzed at the Clinical Research Unit, University of Kuopio by enzymatic photometric method (Kone Pro Analysator, Kone Instruments, Finland) using commercial kits (CHOL CHOD-PAP, Peridochrom triacylglycerols GPO-PAP, Boehringer Mannheim GmbH, Germany). During the study, the intra-assay coefficients of variation were 0.5 -1.7% for serum total cholesterol, 0.3 -0.8% for serum HDL cholesterol and 1.2 -2.9% for serum total triacylglycerol, and the interassay coefficients of variation were 1.0% for total cholesterol, 1.4% for HDL cholesterol and 1.0% for total triacylglycerol. Serum LDL cholesterol concentration was calculated by Friedewald's formula (Friedewald et al, 1972) .
Blood pressure was measured from the right arm after 10 min of rest in a sitting position with a mercury sphygmomanometer (Mercuro 300, Speidel & Keller GmpH & Co., Germany) at the every visit. Three measurements were obtained and the mean of the last two was used in the analyses. The disappearance of Korotkoff's sounds (phase V) was used to determine diastolic blood pressure. Weight with light clothing was measured twice (mean was used in analyses) at every visit with a digital scale (Scale Seca 707, Vogel & Falke GmpH & Co, Germany). Height to the closest 0.5 cm was measured at the first visit.
Statistical methods
The data were analyzed with the SPSS 10.05 (SPSS Inc., Chicago, IL, USA) statistical package. All data are presented as means and standard deviations. Absolute and percentage differences in serum lipid concentrations are also presented with the 95% confidence interval for the mean. Before further analyses the normal distribution of variables was checked with the Shapiro -Wilk test. The means of dietary variables between the test periods were analyzed with paired samples t-test. To compare the mean body weight, body mass index, serum lipids and blood pressure between the test periods the general linear model (GLM) analysis for repeated measures was carried out. Further analyses were done with paired samples t-test with Bonferoni adjustment. For variables (some laboratory measurements, consumption of test cheese and some dietary variables) which were not normally distributed even after logarithmic or other mathematical transformation the Friedman test was used and further analysis was done with Wilcoxon signed-rank test.
Results
The mean body weight in men and women did not change significantly during the study (data not shown). The study subjects' exercise and smoking habits and consumption of alcohol remained stable during the study. Three of the study subjects had some minor changes, not related to lipid metabolism, in their medication for the treatment of eye and gastrointestinal symptoms and hypertension. According to the structured interview two subjects changed their hormonal preparation to different trademark during the study, but the pharmacological agent remained the same.
The compliance with the use of test products was good and there were no significant differences in compliance between the test periods. The average total amount of test cheese used per study subject was 65.0 ( AE 0) g=day on rapeseed oil-based cheese period and 64.6 ( AE 2.0) g=day in the control period. During the study the test cheeses replaced most of the habitual cheeses or cold cuts in the subjects' habitual diet.
The intakes of energy and nutrients from the diet during the different test periods are presented in Table 3 . The energy intake did not differ between the test periods. The proportion of fat as a source of energy was slightly lower on the rapeseed oil-based cheese period than on control period and respectively, the proportion of protein was higher. There was a significant difference (P < 0.001) in the fatty acid composition of the diet during the different test periods. When compared with the control period, the vitamin A content of the diet was lower (P ¼ 0.016) and vitamin E content higher (P < 0.001) on the rapeseed oil-based cheese period.
Serum total (P < 0.001) and LDL (P ¼ 0.002) cholesterol concentrations were significantly lower during the rapeseed oil based-cheese period than during the control period (Table  4 ). In addition, there were also significant interactions between the order of the study periods and the effect of the test cheese on serum HDL cholesterol (P ¼ 0.006) and triacylglycerol (P ¼ 0.005) concentrations. In further testing the group beginning with the use of rapeseed oil basedcheese had lower HDL cholesterol concentrations (P ¼ 0.002) after the rapeseed oil based-cheese period than after the control cheese period. The group beginning with Effect of vegetable oil-based cheese HM Karvonen et al the use of control cheese had lower triacylglycerol concentrations (P ¼ 0.02) after 2 weeks' use of rapeseed oil-based cheese than after the control cheese. The absolute and percentage differences in serum and lipoprotein lipids compared to the control cheese are shown in Table 5 . Compared to the control cheese period serum total cholesterol concentration was 6.7% lower after 2 weeks' use and 5.0% lower after 4 weeks' use of rapeseed oilbased cheese. Respectively, LDL cholesterol concentration was 7.0% lower after 2 weeks and 6.4% lower after 4 weeks' use of rapeseed oil-based cheese. The individual differences in total and LDL cholesterol concentrations between the two study periods are presented in Figure 2 .
In the beginning of the intervention the mean systolic blood pressure of all study subjects was 131 ( AE 19) mmHg and the mean diastolic blood pressure 83 ( AE 10) mmHg. During cheese consumption systolic blood pressure ranged from 127 to 128 mmHg and diastolic blood pressure from 81 to 83 mmHg. There were no significant differences in systolic or diastolic blood pressure between the test periods. However, compared to the pre-trial measurements (weeks 7 2 and 0) the systolic blood pressure was lower during the consumption of both test cheeses.
Discussion
Fat modification of cheese had a significant effect on serum and lipoprotein lipid concentrations. During the rapeseed oil-based cheese period total cholesterol concentration was 6.7% lower after 2 weeks' use of cheese and 5.0% lower after 4 weeks' use compared to the control cheese period. This reduction in serum total cholesterol was due to a decrease in LDL cholesterol concentration. Interestingly, the single change in the dietary habit resulted in a decline in serum total cholesterol concentration similar to reductions achieved by general dietary advices at the population level (Tang et al, 1998) .
Compliance with the use of test products was very good and no changes other than those intended took place in the diet of the study subjects during the study. There were no changes in the body weight or lifestyles of the study subjects. The minor changes in the medication cannot be considered to affect the results. Altogether changes in serum lipid profile could be ascribed to the use of test cheeses.
As to the portion size, the daily amount of test cheese was 65 g. This is slightly more than the average daily 47 g cheese consumption in European Union countries (King, 1999) and 35 g in the USA (Putnam & Allshouse, 1999) , but represents a typical daily portion of cheese eaters in Finland (National Public Health Institute, Department of Nutrition, 1998). However, the study subjects, who were typical hypercholesterolemic subjects, found it quite feasible to use the intended amount of cheese per day. Therefore, this study represents the potential benefit that an average, hypercholesterolemic subject using cheese regularly may gain by changing from milk-fat-based cheese to rapeseed oilbased cheese. The differences in fatty acid composition, vitamin A content and vitamin E content of the diets between the test periods were parallel to the differences of fatty acid composition and vitamin content of the test cheeses. Rapeseed oil-based cheese had a very low content of saturated fatty acids and high content of unsaturated fatty acids when compared to milk-fat-based cheese. Further, rapeseed oilbased cheese contained plenty of vitamin E, but little vitamin A compared to the control cheese. All changes in dietary Figure 2 Individual (n ¼ 31) differences in total and LDL cholesterol concentrations after 4 weeks' use of rapeseed oil-based cheese in reference to the concentrations after 4 weeks' use of milk-fat-based cheese (0-line).
Effect of vegetable oil-based cheese HM Karvonen et al intake could be ascribed to be consequences of the alternation of cheese type.
The beneficial effect of rapeseed oil as such on the serum cholesterol concentration has been demonstrated in several studies (Bierenbaum et al, 1991; Lichtenstein et al, 1993; Sarkkinen et al, 1994; Valsta et al, 1992) . Among others, in the study of Seppänen-Laakso et al, (1992) , exchange of butter on bread to rapeseed oil-based margarine caused a 9.1% reduction in serum total cholesterol concentration, when on average 8% of total energy intake was derived from rapeseed oil based margarine. In the present study approximately 5% of the energy was derived from rapeseed oil.
The cholesterol-lowering efficacy of the fat-modified cheese used in the present study is in agreement with a previous cross-over study by Davis et al (1993) . In that study the daily consumption of 100 g of vegetable oil-based mozzarella cheese for 2 months decreased total cholesterol by 6% and LDL cholesterol concentrations by 9%, when compared with the cholesterol concentrations after 2 months' consumption of partially skim-milk-based mozzarella.
All the milk fat in the fatty acid modified cheese of the present study was removed and replaced by rapeseed oil during the cheese manufacturing. In some studies the test products have been produced from fatty acid modified milk, derived through feedlot technology (Noakes et al, 1996; Tholstrup et al, 1998) . These fatty acid-modified dairy products contained less saturated fatty acids and more unsaturated fatty acids than ordinary dairy products, and they have been shown to have a lowering effect on serum cholesterol concentrations, but more modest than in the present study. Noakes et al (1996) demonstrated that fat-modified dairy products lowered plasma cholesterol concentrations by 4.3%, whereas in the study of Tholstrup et al (1998) the cholesterol concentrations were not changed significantly.
It should be noted that the changes in the serum cholesterol concentrations in the present study were in line with those calculated by prediction equations for diet mediated changes in serum total cholesterol concentrations (Howell et al, 1997) . The actual dietary differences between the study periods predicted a change in serum total cholesterol of 7 0.36, 7 0.37 and 7 0.27 mmol=l calculated by equations of Keys et al (1957) ; Hegsted et al (1993) and Howell et al (1997) , respectively. The actual changes in this study were 7 0.45 mmol=l at week 2 and 7 0.32 mmol=l at week 4. In addition to the changes in fatty acid of the diet the enhancement in plant sterol intake (99 mg=day) might contribute a little (less than 1%) to the cholesterol-lowering effect (Hendriks et al, 1999) .
In the present study systolic and diastolic blood pressure levels were not significantly affected by fatty acid modification of the cheese. The results of the present study are similar to those of Mutanen et al (1992) , who found that in normotensive patients blood pressure was not altered by modifying fatty acid composition of the diet with rapeseed or sunflower oil. Fat modification is known to have a more marked effect on blood pressure in hypertensive than in normotensive subjects (Puska et al, 1985) . Higher systolic blood pressure in pre-trial measurements (weeks 7 2 and 0) than during the consumption of both test cheeses is most likely due to the well-recognized observation that blood pressure normally declines with repeated measures.
It is of note that this single dietary modification has clinically significant effect on serum total and LDL cholesterol concentrations. Thus our results have major practical implications; rapeseed oil based-cheese offers a new vehicle to accomplish a hypo-cholesterolemic diet and to keep nutritionally valuable food item, cheese, in the diet of hypercholesterolemic patients.
In conclusion, the present study showed that rapeseed oilbased cheese reduces serum total and LDL cholesterol concentrations by 5.0=6.4% in mildly to moderately hypercholesterolemic subjects when replacing ordinary milk-fat-based cheese in a habitual diet of subjects using cheese regularly.
